University of Miami under fire for hiring psychiatrist who took millions in Pharma funds and was “pharma pimping for Paxil”

cchrint — Fri, 06 Nov 2009 19:10:19 +0000

John Dorschner
The Miami Herald
November 6, 2009

Charles Nemeroff, an Atlanta psychiatrist who was the subject of a Senate investigation concerning huge sums he received from drug companies, has been named chairman of the psychiatry department at the University of Miami.

Last year Nemeroff, as the top psychiatrist at Emory University, was the focus of an investigation by Sen. Charles Grassley, R-Iowa, who said he was concerned about the millions the psychiatrist received from drug companies while conducting supposedly unbiased research for the National Institutes of Health on drugs made by the companies he was receiving money from.

On Thursday, Pascal Goldschmidt, dean of UM medical school, called Nemeroff “an exceptional psychiatrist and an exceptional scientist who has one issue in which he recognizes he made a mistake,” in not telling Emory how much he was getting from drug makers.

Goldschmidt said he had read investigative reports from Emory about Nemeroff’s activities and Emory found nothing to indicate that payments the psychiatrist received had in any way influenced his research results.

Elsewhere, opinions are divided.

The former head of psychiatry at Duke University told The Miami Herald Thursday that Nemeroff was “economical with the truth” and his work can’t be trusted, while the leader of the Columbia University psychiatry program said Nemeroff was a top-flight scientist and he had never seen any bias in his work.

Read entire article: http://www.miamiherald.com/business/story/1319569.html

« Return to news items

News Feed

Say what? Psychiatrist Charles Nemeroff who failed to report $1.2 mil in Pharma deals lands psych chairmanship at University

cchrint — Thu, 05 Nov 2009 23:17:40 +0000

John Dorschner
The Miami Herald
November 5, 2009

Charles Nemeroff, an Atlanta psychiatrist who was the subject of a Senate investigation concerning huge sums he received from drug companies, is being named chair of the psychiatry department at the University of Miami medical school.

Last year Nemeroff, as chair of the Department of Psychiatry at Emory University, was the intense focus of an investigation by Sen. Charles Grassley, R-Iowa, who said he was concerned about the money the psychiatrist received from drug companies while conducting supposedly unbiased research for the National Institutes of Health on drugs made by the companies he was receiving money from.

On Thursday, Pascal Goldschmidt, dean of UM medical school, called Nemeroff “an extraordinary psychiatrist and scientist. . . . He got into serious trouble on disclosure on conflict of interest.”

Goldschmidt said he had read investigative reports from Emory about Nemeroff’s activities and found nothing to indicate that payments the psychiatrist received had in any way influenced his research results.

In a telephone interview at mid-day Thursday, Nemeroff, 60, told The Miami Herald he was excited to be coming to Miami. “I think it’s going to be a top-10 school.”

A front-page report by The New York Times in October 2008 said that congressional investigators found Nemeroff — “one of the nation’s most influential psychiatrists” — had received $2.8 million in consulting deals with drug makers over seven years and failed to report at least $1.2 million of that to Emery University.

Read entire article: http://www.miamiherald.com/news/breaking-news/story/1318257.html

« Return to news items

News Feed

CCHR International » University of Miami

University of Miami under fire for hiring psychiatrist who took millions in Pharma funds and was “pharma pimping for Paxil”

Related Posts

Say what? Psychiatrist Charles Nemeroff who failed to report $1.2 mil in Pharma deals lands psych chairmanship at University

Related Posts